ARCHIVES

In Brief: FDA Oncological Drugs Advisory Committee Gets New Charter, Georgetown’s Schein Is Chairman

This article is from The Cancer Letter archive.

Vol. 04 No. 41 | October 13, 1978

Download PDF Visit The Full Archive

Related Articles

In Brief: ACCC to Bid On Ovarian Cancer Treatment RFP; Community MDs Handle 90% Of Ovarian Patients

September 5, 1975

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

NIDA Supports Phase III Trial of Anti-Tobacco Vaccine

November 6, 2009

Cyclamate Committee Finds No Proof Of Carcinogenicity

January 23, 1976

Iniparib Plus Chemo Shows Benefit In Phase II Study

January 28, 2011

In Brief: HHS Rejects Sole Source Award For Utah Study; Reagan Proclaims April Cancer Control Month

April 3, 1981